Biotalys
Biotalys NV (formerly Agrosavfe) is a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on its groundbreaking technology platform, Biotalys has developed a broad pipeline of effective and safe products that address key crop pests and diseases. Combining the high-performance characteristics and consistency of chemicals with the clean safety profile of biologicals, Biotalys provides ideal crop protection agents for both pre-and post-harvest applications. Biotalys’ lead biofungicide, BioFun-1, has demonstrated consistent, high efficacy against major pests in a global fruit and vegetables field trial. The company expects to launch BioFun-1 in the U.S. in 2022, followed by global market introductions.
Sector
Industrial Biotech
Strategy
Industrial Biotech
Status
Live
Website
biotalys.com
Related News
Biotalys appoints Kamal El Mernissi as Chief Business Development Officer
Biotalys announces closing of private placement
Biotalys receives approval for large-scale demonstration trials of EVOCA in the Netherlands
Biotalys starts field trials for second Biofungicide
Biotalys appoints Laura J. Meyer to Board of Directors
SofinnovaCapital
The Sofinnova Capital Strategy acts as a founding and lead investor in early-stage biopharma and medtech start-ups focusing on groundbreaking therapeutic technologies.
SofinnovaMD Start
The MD Start Strategy is Sofinnova’s in-house medtech accelerator. The team’s hands-on entrepreneurial expertise contributes to the platform's global leadership in company building.
SofinnovaCrossover
The Sofinnova Crossover Strategy supports ground-breaking innovations in later-stage biotech and medtech companies, enabling ambitious life sciences companies to reach their full potential.
SofinnovaIndustrial Biotech
Our Industrial Biotech Strategy seeks early-stage investments that will have a positive impact on sustainability in the chemicals, agriculture, food and materials sectors.
SofinnovaTelethon
The Sofinnova Telethon Strategy seeks early-stage projects to bring the best Italian science to the world stage.
SofinnovaDigital Medicine
The Sofinnova Digital Medicine Strategy backs early-stage startups at the intersection of biology, data and computation.
SofinnovaBiovelocita
The Sofinnova Biovelocita Strategy is dedicated entirely to the creation and acceleration of European biotech startups, in partnership with leading research organizations.